<?xml version="1.0"  ?><!DOCTYPE pmc-articleset PUBLIC "-//NLM//DTD ARTICLE SET 2.0//EN" "https://dtd.nlm.nih.gov/ncbi/pmc/articleset/nlm-articleset-2.0.dtd"><pmc-articleset><article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xml:lang="en" article-type="research-article" dtd-version="1.4"><!--The publisher of this article does not allow downloading of the full text in XML form.--><front><journal-meta><journal-id journal-id-type="nlm-ta">Curr Opin HIV AIDS</journal-id><journal-id journal-id-type="iso-abbrev">Curr Opin HIV AIDS</journal-id><journal-id journal-id-type="pmc-domain-id">319</journal-id><journal-id journal-id-type="pmc-domain">nihpa</journal-id><journal-title-group><journal-title>Current opinion in HIV and AIDS</journal-title></journal-title-group><issn pub-type="ppub">1746-630X</issn><issn pub-type="epub">1746-6318</issn><custom-meta-group><custom-meta><meta-name>pmc-is-collection-domain</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-collection-title</meta-name><meta-value>NIHPA Author Manuscripts</meta-value></custom-meta></custom-meta-group></journal-meta><article-meta><article-id pub-id-type="pmcid">PMC12259018</article-id><article-id pub-id-type="pmcid-ver">PMC12259018.1</article-id><article-id pub-id-type="pmcaid">12259018</article-id><article-id pub-id-type="pmcaiid">12259018</article-id><article-id pub-id-type="manuscript-id">NIHMS2073908</article-id><article-id pub-id-type="pmid">40397570</article-id><article-id pub-id-type="doi">10.1097/COH.0000000000000948</article-id><article-id pub-id-type="manuscript-id-alternative">NIHMS2073908</article-id><article-id pub-id-type="manuscript-id-alternative">NIHPA2073908</article-id><article-version article-version-type="pmc-version">1</article-version><article-categories><subj-group subj-group-type="heading"><subject>Article</subject></subj-group></article-categories><title-group><article-title>Balancing Polypharmacy and Comorbidity Management: Cardiovascular Health</article-title></title-group><contrib-group><contrib contrib-type="author"><name name-style="western"><surname>Rock</surname><given-names initials="AE">Alex E.</given-names></name><degrees>PharmD AAHIVP BCPS BCIDP</degrees><xref rid="A1" ref-type="aff">1</xref><xref rid="A2" ref-type="aff">2</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Russell</surname><given-names initials="ML">Matthew L.</given-names></name><degrees>MD</degrees><xref rid="A3" ref-type="aff">3</xref><xref rid="FN1" ref-type="author-notes">*</xref></contrib><contrib contrib-type="author"><name name-style="western"><surname>Triant</surname><given-names initials="VA">Virginia A.</given-names></name><degrees>MD MPH</degrees><xref rid="A2" ref-type="aff">2</xref><xref rid="A4" ref-type="aff">4</xref><xref rid="FN1" ref-type="author-notes">*</xref></contrib></contrib-group><aff id="A1"><label>1</label>Department of Pharmacy, Massachusetts General Hospital, Boston, Massachusetts</aff><aff id="A2"><label>2</label>Division of Infectious Diseases, Massachusetts General Hospital, Boston, Massachusetts</aff><aff id="A3"><label>3</label>Division of Geriatric Medicine, Massachusetts General Hospital, Boston, Massachusetts</aff><aff id="A4"><label>4</label>Division of General Internal Medicine, Massachusetts General Hospital, Boston, Massachusetts</aff><author-notes><fn fn-type="equal" id="FN1"><label>*</label><p id="P1">Authors contributed equally</p></fn><corresp id="CR1"><bold>Corresponding author:</bold> Virginia Triant, MD, MPH, 100 Cambridge Street, Suite 1600, Boston, MA 02114, <email>vtriant@mgh.harvard.edu</email></corresp><fn fn-type="COI-statement" id="FN2"><label>3.</label><p id="P22">Conflicts of interest: none</p></fn></author-notes><pub-date pub-type="ppub"><day>01</day><month>7</month><year>2025</year></pub-date><pub-date pub-type="epub"><day>13</day><month>5</month><year>2025</year></pub-date><volume>20</volume><issue>4</issue><issue-id pub-id-type="pmc-issue-id">492871</issue-id><fpage>409</fpage><lpage>415</lpage><pub-history><event event-type="nihms-submitted"><date><day>13</day><month>04</month><year>2025</year></date></event><event event-type="pmc-release"><date><day>13</day><month>05</month><year>2026</year></date></event><event event-type="pmc-released-under-embargo"><date><day>15</day><month>07</month><year>2025</year></date></event><event event-type="pmc-last-change"><date iso-8601-date="2025-07-15 16:25:18.810"><day>15</day><month>07</month><year>2025</year></date></event></pub-history><self-uri xmlns:xlink="http://www.w3.org/1999/xlink" content-type="pmc-pdf" xlink:href="nihms-2073908.pdf"/><abstract id="ABS1"><sec id="S1"><title>Purpose of review:</title><p id="P2">This review will discuss statin therapy for prevention of cardiovascular disease (CVD) among people with HIV (PWH) in the context of balancing prevention and treatment of chronic diseases with challenges related to polypharmacy.</p></sec><sec id="S2"><title>Recent findings:</title><p id="P3">Aging PWH confront an increased risk of chronic diseases, resulting in the need for prevention and treatment of comorbidities in addition to antiretroviral therapy (ART). Paradigm-shifting data from the REPRIEVE trial demonstrated a reduction in CVD events with statin therapy among PWH at low to moderate CVD risk, prompting the Department of Health and Human Services (HHS) to recommend statin therapy for primary prevention of CVD in people with HIV aged 40&#8211;75 years. Statins should be initiated according to guideline recommendations for CVD prevention, and discussion of statin initiation should include consideration of concurrent medications and the potential effects of polypharmacy.</p></sec><sec id="S3"><title>Summary:</title><p id="P4">Statins should be initiated for primary prevention of CVD in people with HIV age 40&#8211;75 years. The effects of polypharmacy should be considered in all aging PWH. Prevention and treatment of chronic diseases among PWH is important to reduce morbidity and mortality and promote healthy aging.</p></sec></abstract><kwd-group><kwd>HIV</kwd><kwd>polypharmacy</kwd><kwd>cardiovascular</kwd><kwd>aging</kwd><kwd>statin</kwd></kwd-group><custom-meta-group><custom-meta><meta-name>pmc-exception-type</meta-name><meta-value>EMBARGO</meta-value></custom-meta><custom-meta><meta-name>pmc-status-qastatus</meta-name><meta-value>4</meta-value></custom-meta><custom-meta><meta-name>pmc-status-live</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-status-embargo</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-status-released</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-open-access</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-olf</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-manuscript</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-legally-suppressed</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-pdf</meta-name><meta-value>yes</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-has-supplement</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-pdf-only</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-suppress-copyright</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-real-version</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-is-scanned-article</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-preprint</meta-name><meta-value>no</meta-value></custom-meta><custom-meta><meta-name>pmc-prop-in-epmc</meta-name><meta-value>no</meta-value></custom-meta></custom-meta-group></article-meta></front></article></pmc-articleset>